Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes - The Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)

被引：62
作者：
Meier, JJ
Deifuss, S
Klamann, A
Launhardt, V
Schmiegel, WH
Nauck, MA
机构：
[1] Diabetszentrum Bad Lauterberg, D-37431 Bad Lauterberg im Harz, Germany
[2] Ruhr Univ Bochum, Dept Med, D-4630 Bochum, Germany
[3] Univ Calif Los Angeles, Larry Hillblom Islet Res Ctr, David Geffen Sch Med, Los Angeles, CA USA
来源：
DIABETES CARE | 2005年 / 28卷 / 10期
关键词：
D O I：
10.2337/diacare.28.10.2551
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2551 / 2553
页数：3
相关论文
共 10 条
[1]   Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction [J].
Aronson, D ;
Rayfield, EJ ;
Chesebro, JH .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (04) :296-306
[2]   Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview [J].
Capes, SE ;
Hunt, D ;
Malmberg, K ;
Gerstein, HC .
LANCET, 2000, 355 (9206) :773-778
[3]   Myocardial infarction in diabetic vs non-diabetic subjects - Survival and infarct size following therapy with sulfonylureas (glibenclamide) [J].
Klamann, A ;
Sarfert, P ;
Launhardt, V ;
Schulte, G ;
Schmiegel, WH ;
Nauck, MA .
EUROPEAN HEART JOURNAL, 2000, 21 (03) :220-229
[4]   Glycometabolic state at admission:: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction -: Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study [J].
Malmberg, K ;
Norhammar, A ;
Wedel, H ;
Rydén, L .
CIRCULATION, 1999, 99 (20) :2626-2632
[5]   FASTTRACK Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2):: effects on mortality and morbidity [J].
Malmberg, K ;
Rydén, L ;
Wedel, H ;
Birkeland, K ;
Bootsma, A ;
Dickstein, K ;
Efendic, S ;
Fisher, M ;
Hamsten, A ;
Herlitz, J ;
Hildebrandt, P ;
MacLeod, K ;
Laakso, M ;
Torp-Pedersen, C ;
Waldenström, A .
EUROPEAN HEART JOURNAL, 2005, 26 (07) :650-661
[6]   Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus [J].
Malmberg, K .
BRITISH MEDICAL JOURNAL, 1997, 314 (7093) :1512-1515
[7]  
Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437
[8]   Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes -: The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA) [J].
Meier, JJ ;
Deifuss, S ;
Klamann, A ;
Schmiegel, W ;
Nauck, MA .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (06) :344-350
[9]   IN-HOSPITAL PROGNOSIS OF PATIENTS WITH FASTING HYPERGLYCEMIA AFTER 1ST MYOCARDIAL-INFARCTION [J].
OSULLIVAN, JJ ;
CONROY, RM ;
ROBINSON, K ;
HICKEY, N ;
MULCAHY, R .
DIABETES CARE, 1991, 14 (08) :758-760
[10]   DETERMINANTS AND IMPORTANCE OF STRESS HYPERGLYCEMIA IN NONDIABETIC PATIENTS WITH MYOCARDIAL-INFARCTION [J].
OSWALD, GA ;
SMITH, CCT ;
BETTERIDGE, DJ ;
YUDKIN, JS .
BMJ-BRITISH MEDICAL JOURNAL, 1986, 293 (6552) :917-922
1